Australia markets open in 6 hours 55 minutes

Gene Biotherapeutics, Inc. (CRXM)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
As of 03:22PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
Total revenue
0
0
Operating expenses
Research development
217.582
217.582
Selling general and administrative
1,045
1,045
Total operating expenses
1,262
1,262
Operating income or loss
-1,262
-1,262
Interest expense
57.4
57.4
Total other income/expenses net
-173.555
668.032
Income before tax
-651.55
-651.55
Income from continuing operations
-651.55
-651.55
Net income
-517.897
-517.897
Net income available to common shareholders
-517.897
-517.897
Basic EPS
-0.02
-
Diluted EPS
-0.02
-
Basic average shares
24,116
-
Diluted average shares
24,116
-